publicações selecionadas
-
artigo académico
- Engineering a Hybrid Ti6Al4V-Based System for Responsive and Consistent Osteogenesis. ACS Omega. 2024
- Editorial: Disease-on-a-chip: from point-of-care to personalized medicine. Frontiers in Pharmacology. 2023
- Non-invasive diagnosis and monitoring tool of children¿s mental health: A point-of-care immunosensor for IL-6 quantification in saliva samples. Frontiers in Aging Neuroscience. 2022
- Faecal Diagnostic Biomarkers for Colorectal Cancer. Cancers. 2021
- Intratumoral VEGF nanotrapper reduces gliobastoma vascularization and tumor cell mass. Journal of Controlled Release. 2021
- Non-invasive molecular assessment of human embryo development and implantation potential. Biosensors & Bioelectronics. 2020
- Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology. Journal of Personalized Medicine. 2019
- Electrochemical Immunosensor for TNFa-Mediated Inflammatory Disease Screening. ACS Chemical Neuroscience. 2019
- Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity. Acta Biomaterialia. 2018
- Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics. Frontiers in Molecular Neuroscience. 2018
- Collar occupancy: A new quantitative imaging tool for morphometric analysis of oligodendrocytes. Journal of Neuroscience Methods. 2018
- Mechanical plasticity during oligodendrocyte differentiation and myelination. Glia. 2017
- A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles. Acta Cytologica. 2017
- Expression of Rac1 alternative 3' UTRs is a cell specific mechanism with a function in dendrite outgrowth in cortical neurons.. Biochimica et biophysica acta. 2017
- Implications of polyadenylation in health and disease. 2014
- Cutting edge: IFN-¿ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. Journal of Immunology. 2006
- Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated Sialyl-Tn antigen. Cancer Research. 2004
- Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. 2003
-
artigo de conferência
- PBS Finder 2015
- Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on innate immune responses and the outcome of infection 2012
- BCG Infection Induces IL-17 Producing Antigen-Specific T cells 2004
- Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen 2004
-
artigo de revista
- IL-17A Promotes Intracellular Growth of Mycobacterium by Inhibiting Apoptosis of Infected Macrophages. Frontiers in Immunology. 2015
- BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4<sup>+</sup>IL-17<sup>+</sup>TNF<sup>+</sup>IL-2<sup>+</sup> T cells. Vaccine. 2015
- Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response. Antibiotics. 2013
- Mycobacterium ulcerans Triggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression. Infection and Immunity. 2011
-
TLR2 deficiency by compromising p19 (IL-23) expression limits T
h 17 cell responses to Mycobacterium tuberculosis. International Immunology. 2011 - The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment. Inflammation Research. 2010
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. Journal of Experimental Medicine. 2010
- Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections. Current Topics in Medicinal Chemistry. 2008
- A New Model of Laryngitis: Neuropeptide, Cyclooxygenase, and Cytokine Profile. Laryngoscope. 2008
- Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis. International Journal of Antimicrobial Agents. 2008
-
capítulo de livro
-
documento
- Mechanical traits uncover functional plasticity and identity of tissue-specific macrophages 2018
- An improvement of anti-angiogenic therapy achieved by bevacizumab delivery through PLGA nanocarriers 2018
- Alternative 3' UTRs expression of Rac1 is a cell-type specific mechanism that controls neurite outgrowth 2017
- A new paradigm for antiangiogenic therapy through controlled release of bevacizumab 2017
- Electrochemical-based sensing device for the detection of inflammatory cytokines 2017
- Identification of actomyosin-based biomarkers relevant for microglia activation 2017
- Study of stability and bioactivity of bevacizumab- loaded PLGA nanoparticles towards its controlled release 2017
- The role of PABPC1 and YBX1 in Oligodendrocyte differentiation 2015
- Role of PABPC1 and YBX1 in oligodendrocyte differentiation 2015
- The oligodendrocyte “processosome”: identification of new regulators of differentiation and myelination 2015
- Alternative polyadenylation of Rho GTPases in central nervous system cells 2014
- Role of RNA-binding proteins in oligodendrocyte differentiation 2014
- Alternative Polyadenylation of Rho GTPases: a gene/cell specific process 2014
- Alternative polyadenylation of Rho GTPases: a gene and cell specific process 2014
- Expression Regulation of Rho GTPases family members during oligodendrocytes differentiation and myelination 2014
- Role of PABPC1 and YBX1 in oligodendrocyte differentiation 2014
- Development of purine derivatives with activity against Mycobacterium tuberculosis Infections: potential of chitosan-coated magnetic nanoparticles for controlled delivery 2013
- Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on innate immune responses and the outcome of infection: P1313 2012
- BCG vaccination inducing long-term protection against Mycobacterium tuberculosis correlates with the differentiation of IL-17/IL-2/TNF producing T cells 2012
- Differential TLR usage by Mycobacterium tuberculosis strains modulates innate immune responses with an impact on the outcome of infection 2012
- Differential recognition of Mycobacterium tuberculosis strains by TLRs impacts innate immune responses and the outcome of infection 2012
- IL-17 and IL-10 cooperate to prevent apoptosis of Mycobacterium-infected macrophages 2012
- Mycobacterium tuberculosis and M. bovis BCG differentially trigger IL-10 production by dendritic cells with an impact on IL-12 2012
- Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on innate immune responses and the outcome of infection 2012
- Mycobacterium tuberculosis or M. bovis BCG regulate IL-12 expression differently in infected Dendritic Cells 2011
- IL-17 interferes with p53 and prevents apoptosis of Mycobacterium-infected macrophages 2010
- Control of Mycobacterium tuberculosis infection depends on the time of previous exposure to BCG vaccination 2009
- Dendritic cells exposed to Mycobacterium tuberculosis and Mycobacterium. bovis BCG induce a distinct balance of T helper responses 2009
- Mycobacterium tuberculosis and M. bovis BCG induce a differential expression of IL-12 family of cytokines on BMDC 2009
- Over-expression of IL-10 increases resistance to Mycobacterium tuberculosis infection 2009
- TLR2 controls IL-17 responses to Mycobacterium tuberculosis 2009
- Dynamics of Th1 and Th17 cells varies with time post-BCG vaccination: implications on protection conferred to Mycobacterium tuberculosis infection 2008
- Changes in the expression of inflammatory mediators following neurogenic laryngitis: therapeutical trial with etoricoxib 2006
- IFNg induces LRG-47 and Nitric Oxide in macrophages, playing a protective role in infection by a mycolactone-negative strain of Mycobacterium ulcerans 2006
- IFNg regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection 2006
- IL-17 inhibits IFN-g inducing bactericidal activity on macrophages infected with mycobacteria 2006
- IL-17 inhibits the bactericidal activity of macrophages infected with Mycobacterium by preventing cell death 2006
- IL-17-producing CD4 T cells induced during mycobacterial infection are regulated by IFNg” 2006
- Possible alternative therapies to chronic laryngitis and laryngeal cancer: the use of COX-2 specific inhibitors and detection of tumoral markers 2006
- Th17 cells inducing a massive recruitment of neutrophils may play a role in Koch´s reaction 2006
- BCG Infection Induces IL-17 Producing Antigen-specific T cells 2004
- Expression and characterisation of recombinant human ST6GalNAc-I and ST6GalNAc-II 2003
- 1,3 – Propanediol continuous production by Clostridium butyricum VPI1718: Effect of dilution rate and substrate concentration 1999